← Leaderboards
David S Wilkes
Indiana Univ-Purdue Univ At Indianapolis
$20,859,091
Attributed
$21,981,752
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.5M · FY2005–14$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$29,683,981 · 12
By mechanism
R01$9,701,076 · 4
P01$9,641,293 · 3
G20$8,386,919 · 1
T32$836,341 · 1
R21$661,884 · 1
T35$316,282 · 1
Top collaborators
- Jason D Christie4 shared
Others in their field
Top investigators on “Lung Transplantation”
- Charles A Coltman · Southwest Oncology Group$55,198,633
- Mary M Horowitz · Medical College Of Wisconsin$47,632,939
- Joren C Madsen · Massachusetts General Hospital$38,316,945
- Scott M Palmer · Duke University$32,759,902
- Michael L. Terrin · Clinical Trials And Surveys Corporation$29,907,079
- Craig B Thompson · Sloan-Kettering Inst Can Research$27,714,083
Research focus
Lung TransplantationLungAutoimmunityLung DiseasesReportingTransplantationCollagen Type VCollagenProgramsImmunityPathogenesisPathologyRattusT-LymphocyteImmune ResponseChronicAcuteMediatingCytokineLaboratoriesStagingAntibodiesInterleukin-17Risk Factors
Grant awards (55)
TH17 Autoimmunity to Type V Collagen in Heart and Lung Transplant$1,571,078
P01 · FY2014 · AI · contact PI
IL-17A and anti-col (V) humoral immunity in lung allograft rejection$279,237
P01 · FY2014 · AI · contact PI
Administrative Core$63,312
P01 · FY2014 · AI · contact PI
TH17 Autoimmunity to Type V Collagen in Heart and Lung Transplant$1,458,013
P01 · FY2013 · AI · contact PI
Role of anti-Col (V) immunity in primary graft dysfunction$560,115
R01 · FY2013 · HL
IL-17A and anti-col (V) humoral immunity in lung allograft rejection$323,341
P01 · FY2013 · AI · contact PI
Administrative Core$95,493
P01 · FY2013 · AI · contact PI
IU training prog. in molecular physiology and clinical mechanisms of lung disease$80,744
T32 · FY2013 · HL · contact PI
TH17 Autoimmunity to Type V Collagen in Heart and Lung Transplant$1,533,190
P01 · FY2012 · AI · contact PI
Role of anti-Col (V) immunity in primary graft dysfunction$554,933
R01 · FY2012 · HL
IL-17A and anti-col (V) humoral immunity in lung allograft rejection$352,096
P01 · FY2012 · AI · contact PI
IU training prog. in molecular physiology and clinical mechanisms of lung disease$184,768
T32 · FY2012 · HL · contact PI
Administrative Core$96,529
P01 · FY2012 · AI · contact PI
TH17 Autoimmunity to Type V Collagen in Heart and Lung Transplant$1,532,871
P01 · FY2011 · AI · contact PI
Role of anti-Col (V) immunity in primary graft dysfunction$554,979
R01 · FY2011 · HL
Type V Collagen Prevents Lung Allograft Rejection$364,887
R01 · FY2011 · HL · contact PI
IL-17A and anti-col (V) humoral immunity in lung allograft rejection$259,926
P01 · FY2011 · AI · contact PI
IU training prog. in molecular physiology and clinical mechanisms of lung disease$189,019
T32 · FY2011 · HL · contact PI
Administrative Core$91,622
P01 · FY2011 · AI · contact PI
Renovation of the Wells Research Center for a Pediatric Phenotyping Core$8,386,919
G20 · FY2010 · RR · contact PI
TH17 Autoimmunity to Type V Collagen in Heart and Lung Transplant$1,607,077
P01 · FY2010 · AI · contact PI
Role of anti-Col (V) immunity in primary graft dysfunction$575,295
R01 · FY2010 · HL
Type V Collagen Prevents Lung Allograft Rejection$365,254
R01 · FY2010 · HL · contact PI
IL-17A and anti-col (V) humoral immunity in lung allograft rejection$275,014
P01 · FY2010 · AI · contact PI
IU training prog. in molecular physiology and clinical mechanisms of lung disease$191,676
T32 · FY2010 · HL · contact PI
Administrative Core$102,494
P01 · FY2010 · AI · contact PI
Type V Collagen Prevents Lung Allograft Rejection$365,611
R01 · FY2009 · HL · contact PI
IU training prog. in molecular physiology and clinical mechanisms of lung disease$190,134
T32 · FY2009 · HL · contact PI
MMPs in Alloimmune and Autoimmune Lung Disease$402,177
R01 · FY2008 · HL · contact PI
Type V Collagen Prevents Lung Allograft Rejection$367,500
R01 · FY2008 · HL · contact PI
MMPs in Alloimmune and Autoimmune Lung Disease$400,848
R01 · FY2007 · HL · contact PI
Type V Collagen Prevents Lung Allograft Rejection$378,750
R01 · FY2007 · HL · contact PI
MMPs in Alloimmune and Autoimmune Lung Disease$369,849
R01 · FY2006 · HL · contact PI
Immune Responses in Lung Allograft Rejection$356,503
R01 · FY2006 · HL · contact PI
MMPs in Alloimmune and Autoimmune Lung Disease$31,851
R01 · FY2006 · HL · contact PI
MMPs in Alloimmune and Autoimmune Lung Disease$378,750
R01 · FY2005 · HL
Immune Responses in Lung Allograft Rejection$365,408
R01 · FY2005 · HL
Type V Collagen Prevents Lung Allograft Rejection$362,499
R01 · FY2005 · HL
Immune Responses in Lung Allograft Rejection$368,128
R01 · FY2004 · HL
Type V Collagen Prevents Lung Allograft Rejection$362,562
R01 · FY2004 · HL
Immune Responses in Lung Allograft Rejection$369,685
R01 · FY2003 · HL
Type V Collagen Prevents Lung Allograft Rejection$362,623
R01 · FY2003 · HL
Innovative Methods for Immune Tolerance in Lung Transpl*$218,934
R21 · FY2003 · HL
SHORT-TERM TRAINING FOR MINORITY STUDENTS$40,088
T35 · FY2003 · HL
Type V Collagen Prevents Lung Allograft Rejection$367,092
R01 · FY2002 · HL
IMMUNE RESPONSES IN LUNG ALLOGRAFT REJECTION$305,619
R01 · FY2002 · HL
Innovative Methods for Immune Tolerance in Lung Transpl*$221,445
R21 · FY2002 · HL
SHORT-TERM TRAINING FOR MINORITY STUDENTS$102,692
T35 · FY2002 · HL
Type V Collagen Prevents Lung Allograft Rejection$368,093
R01 · FY2001 · HL
IMMUNE RESPONSES IN LUNG ALLOGRAFT REJECTION$250,198
R01 · FY2001 · HL
Innovative Methods for Immune Tolerance in Lung Transpl*$221,505
R21 · FY2001 · HL
SHORT-TERM TRAINING FOR MINORITY STUDENTS$89,667
T35 · FY2001 · HL
IMMUNE RESPONSES IN LUNG ALLOGRAFT REJECTION$191,867
R01 · FY2000 · HL
ACCESSORY CELLS IN LUNG ALLOGRAFT REJECTION$140,186
K14 · FY2000 · HL
SHORT-TERM TRAINING FOR MINORITY STUDENTS$83,835
T35 · FY2000 · HL